United States · FDA National Drug Code directory
Ery
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-962_7d76c42c-5c67-4998-9349-5a3ba099d3e5
- Product NDC
- 45802-962
- Form
- SWAB
- Composition / generic term
- Erythromycin
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080707
- Source listing expiry
- 20271231
Source-listed ingredients
- ERYTHROMYCIN — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 60 APPLICATOR in 1 JAR (45802-962-72) / .8 mL in 1 APPLICATOR · 45802-962-72
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →